BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alomari M, Rashid MU, Chadalavada P, Ragheb J, Zafar H, Suarez ZK, Khazaaleh S, Gonzalez AJ, Castro FJ. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World J Hepatol 2023; 15(4): 477-496 [PMID: 37206648 DOI: 10.4254/wjh.v15.i4.477]
URL: https://www.wjgnet.com/1948-5182/full/v15/i4/477.htm
Number Citing Articles
Muhammed Mubarak. Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunitiesWorld Journal of Gastrointestinal Pathophysiology 2024; 15(1): 92864 doi: 10.4291/wjgp.v15.i1.92864
Zuzana Sumbalová, Jarmila Kucharská, Zuzana Rausová, Anna Gvozdjáková, Mária Szántová, Branislav Kura, Viliam Mojto, Ján Slezák. The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(15): 12477 doi: 10.3390/ijms241512477
Giuseppina Guarino, Felice Strollo, Teresa Della Corte, Ersilia Satta, Sandro Gentile. Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLDDiabetes Therapy 2023; 14(12): 2089 doi: 10.1007/s13300-023-01478-2